Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunotherapy
Study results from University of Genoa provide new insights into immunotherapy
April 11th, 2007
A report, "Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce," is newly published data in Allergy. "Specific Immunotherapy for respiratory allergy is used since about one century and there is now solid documentation of its efficacy. Nevertheless, the methods and experimental designs used in clinical trials are quite heterogeneous and there is no unanimously accepted methodological standard," scientists in Genoa, Italy report. "Many studies are planned with study designs that may not confirm the clinical value of SIT as an effective...
Source: Immunotherapy Weekly (2007-04-11)
|
